Carl Pabo

[3]

• B.S. (summa cum laude) from Yale, Molecular Biophysics and Biochemistry in 1974
• Ph.D. from Harvard, Biochemistry and Molecular Biology in 1980.

Pabo has been a professor at the Johns Hopkins University School of Medicine (1982–1991) and at the Massachusetts Institute of Technology (1991–2001) and an investigator with the Howard Hughes Medical Institute (1986–2001).[4] He's been a visiting professor at Caltech, Stanford, Berkeley and Harvard.[5] At Caltech, he taught a course called “The World in 2050.” [6]

He was chief scientific officer at Sangamo BioSciences from 2001–2003.[7]

In 2018, he founded Humanity 2050 to “to advocate a more comprehensive, coherent way of thinking about the human future.” [8] He also serves as a scientific advisor for NanoDimension. [9]

Pabo became a Guggenheim Fellow in 2005.[10] He is a member of the National Academy of Sciences[11] and of the American Academy of Arts and Sciences.[12] Was awarded the Pfizer Award in Enzyme Chemistry in 1992. He has also won the Protein Society Young Investigator Award and the Pfizer Award in enzymology.[13]